APSR2026-913

 
Late-Breaking
Submitted
Poster Presentation
 
AP03-011
P83
 
Format: PPTX Only
 
Format: PDF Only
10. Respiratory Neurobiology and Sleep
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Kianian Arash * Product Development CNSAC Theilheim Germany
Tahereh Ghafoori - Biotechnology Yeshiva University New York United States
Osama Abu Hassan - Schlaflabor Wiesbaden Schlaflabor Wiesbaden Wiesbaden Germany
-
-
-
-
-
-
-
-
-
-
-
-
Presenting Author Details
Kianian
Arash
ark@cnsac.com
+4915111182864
41-50
Germany
Original Research
A prong-free low-flow oxygen interface for simultaneous nasal and oral oxygen delivery: The NasalOxy® concept
Maximum 25 words
Abstract Content
Conventional low-flow oxygen therapy delivered via nasal cannulas may be limited by oxygen dilution, variability in breathing patterns, and reduced effectiveness during oral breathing. In addition, prolonged intranasal interface use may contribute to mucosal irritation and reduced patient tolerance. This study describes the physiological rationale and clinical implementation concept of a prong-free low-flow oxygen delivery interface designed to support simultaneous nasal and oral oxygen uptake during spontaneous breathing.
A physiology- and workflow-oriented evaluation was conducted using established oxygen therapy principles, published respiratory literature, and device implementation characteristics related to spontaneous breathing and low-flow oxygen delivery. Existing oxygen interfaces were assessed regarding breathing-route dependency, patient comfort, and applicability during routine daily activities. A breathing-zone oxygen delivery concept (NasalOxy®) utilizing localized oxygen enrichment external to the nasal cavity was descriptively evaluated with respect to intended clinical integration and oxygen delivery characteristics.
Conventional nasal cannulas were identified as dependent on intranasal oxygen delivery and therefore potentially limited during oral breathing, speaking, or eating. The evaluated interface was designed to generate a localized oxygen-enriched airflow within the functional breathing zone, enabling simultaneous nasal and oral oxygen uptake without intranasal prongs. The externally positioned interface minimizes direct mucosal interaction while maintaining compatibility with standard low-flow oxygen systems. In controlled observational evaluation, improvements in arterial oxygenation parameters and peripheral oxygen saturation were observed under standard low-flow conditions. Real-world use observations additionally suggested improved interface tolerance and reduced nasal discomfort during prolonged use.
A breathing-zone approach to low-flow oxygen delivery may provide a clinically relevant alternative to anatomy-dependent nasal oxygen interfaces in spontaneously breathing patients. Simultaneous support of nasal and oral oxygen uptake, combined with reduced intranasal interface burden, may improve therapy applicability and patient tolerance during routine daily activities. Prospective controlled clinical studies are warranted to further evaluate oxygenation performance, adherence, and patient-reported outcomes.
 
 
 
 
 
Yes
Yes
https://storage.unitedwebnetwork.com/files/1285/1234573-37089-NasalOxyFig1d_396940.jpg
JPG or JPEG or PNG format ONLY
Low-flow oxygen therapy, Hypoxemia, Respiratory insufficiency
maximum 3 keywords and no abbreviations, separated by commas
 
298